As a botanical drug, oxalidaceae is used in the treatment of various diseases, and in pancreatic cancer cells can inhibit activated SRC, thereby affecting nuclear translocation including STAT3, resulting in low expression of the pro-angiogenic, apoptotic, and cell cycle vascular genes of STAT3 and exerting anti-cancer effects [130]. This evidence concerns the gene STAT3 and pancreatic neoplasm.